RenovoRx (RNXT) Receivables - Net (2024 - 2026)
RenovoRx's (RNXT) quarterly Receivables - Net came in at $480000.0 in Q2 2026, up 32.23% year-over-year from $363000.0 in Q2 2025, and up 71.43% quarter-over-quarter from $280000.0 in Q1 2026.
Analysis
RenovoRx (RNXT) Receivables - Net (2024 - 2026) Analysis & Trends
RenovoRx has disclosed Receivables - Net across 3 years of filings, most recently posting $480000.0 for Q2 2026.
- In Q2 2026, Receivables - Net rose 32.23% year-over-year to $480000.0; the TTM figure through Jun 2026 stood at $480000.0 (up 32.23% YoY), while the FY2025 annual figure was $139000.0, up 223.26% from the prior year.
- Receivables - Net came in at $480000.0 for Q2 2026 at RenovoRx, up from $280000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $480000.0 in Q2 2026 to a low of $43000.0 in Q4 2024.
- Average Receivables - Net over 3 years is $245142.9, with a median of $242000.0 recorded in 2025.
- Year-over-year, Receivables - Net soared 223.26% in 2025 and rose 15.7% in 2026.
- Over 3 years, Receivables - Net stood at $43000.0 in 2024, then soared by 223.26% to $139000.0 in 2025, then jumped by 245.32% to $480000.0 in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $480000.0 in Q2 2026, $280000.0 in Q1 2026, and $139000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn |
| 3 | Medtronic | 117.17 Bn | 108.35 Bn | 6.34 Bn |
| 4 | Stryker | 104.15 Bn | 100.67 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.37 Bn | 62.83 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn |
| 7 | Alcon | 33.01 Bn | 31.55 Bn | 1.68 Bn |
| 8 | Dexcom | 32.16 Bn | 30.22 Bn | 830.00 Mn |
| 9 | Steris | 20.74 Bn | 20.25 Bn | 684.20 Mn |
| 10 | RenovoRx | 83.24 Mn | 83.24 Mn | 766,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 480,000.00 |
| Mar 31, 2026 | 280,000.00 |
| Dec 31, 2025 | 139,000.00 |
| Sep 30, 2025 | 169,000.00 |
| Jun 30, 2025 | 363,000.00 |
| Mar 31, 2025 | 242,000.00 |
| Dec 31, 2024 | 43,000.00 |